Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing

Class:IdLiteratureReference:9713890
_displayNameGenomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing
_timestamp2021-02-02 01:30:27
author[Person:9713894] Saber, Ali
[Person:9713892] van der Wekken, Anthonie J
[Person:9713896] Kok, Klaas
[Person:9713891] Terpstra, M Martijn
[Person:9713899] Bosman, Lisette J
[Person:9713897] Mastik, Mirjam F
[Person:1980019] Timens, W
[Person:9713901] Schuuring, Ed
[Person:9713895] Hiltermann, T Jeroen N
[Person:9713900] Groen, Harry J M
[Person:9713898] van den Berg, Anke
created[InstanceEdit:9713893] Rothfels, Karen, 2021-02-02
journalPLoS One
pagese0153065
pubMedIdentifier27045755
titleGenomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing
volume11
year2016
(literatureReference)[DefinedSet:9700564] crizotinib resistant ALK mutants [plasma membrane] [Homo sapiens]
[FailedReaction:9715357] crizotinib-resistant ALK mutants don't bind crizotinib [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing (9713890)